The digestive system is an incredibly important part of the body, responsible for breaking down food, absorbing nutrients, and eliminating waste. Unfortunately, digestive health issues are incredibly common, with many people suffering from conditions such as irritable bowel syndrome (IBS), Crohn’s disease, and ulcerative colitis. A medication called Trulance (plecanatide) has been approved by the FDA to help improve digestive health, and this article will discuss how doctors can unlock the benefits of Trulance for their patients.
Trulance is a medication that is used to treat adults with chronic idiopathic constipation (CIC) or irritable bowel syndrome with constipation (IBS-C). It is a guanylate cyclase-C agonist, which means that it helps to stimulate the body’s natural production of a hormone called guanylate cyclase-C, which helps to regulate the digestive system. Trulance works by increasing the amount of fluid in the intestines, which helps to soften stools and make them easier to pass.
Trulance works by stimulating the guanylate cyclase-C receptors in the digestive system. These receptors are responsible for regulating electrolyte and water balance in the intestines. When Trulance stimulates these receptors, it causes the intestines to secrete more fluids, which helps to soften stools and make them easier to pass.
The primary benefit of Trulance is that it can help to improve digestive health by relieving symptoms of chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C). Trulance can help to reduce abdominal pain, bloating, and constipation. It can also help to reduce the frequency of bowel movements, and to improve the consistency of stools.
Trulance is primarily used to treat adults with chronic idiopathic constipation (CIC) or irritable bowel syndrome with constipation (IBS-C). It is important to note that Trulance is not recommended for children under the age of 18, as it has not been studied in this age group. It is also not recommended for pregnant or breastfeeding women, as it has not been studied in this population.
Like all medications, Trulance can cause side effects. The most common side effects of Trulance are abdominal pain, flatulence, diarrhea, nausea, and headache. It is important to note that these side effects are generally mild and do not last long. However, if any of these side effects become severe or persist, it is important to contact a doctor.
Trulance is typically taken once daily, with or without food. The recommended dose for adults is 3 mg once daily. It is important to note that Trulance should not be taken more than once daily, as this could increase the risk of side effects.
Trulance is a medication that is used to treat adults with chronic idiopathic constipation (CIC) or irritable bowel syndrome with constipation (IBS-C). It works by stimulating the guanylate cyclase-C receptors in the digestive system, which helps to increase the amount of fluid in the intestines and soften stools. The primary benefit of Trulance is that it can help to improve digestive health by relieving symptoms of CIC and IBS-C. It is important to note that Trulance is not recommended for children under the age of 18, pregnant or breastfeeding women, or those who take more than the recommended dose. Doctors can unlock the benefits of Trulance for their patients by discussing the potential benefits and side effects of the medication, and providing the correct dosing instructions.
1.
Nuclear missile workers are contracting cancer: They blame the bases
2.
Mixed Results With Cyclophosphamide in Mismatched Unrelated Stem Cell Transplants
3.
New analysis helps discern benign from malignant thyroid growths
4.
MCh in Gynecologic Oncology: Admission, Medical School, Fees, Qualifications Information
5.
Even a few mutated cells can significantly impact how blood cancers develop, study finds
1.
Uncovering the Hidden Signs: How to Recognize the Early Symptoms of Colon Cancer
2.
The benefits and risks of taking fludrocortisone for adrenal insufficiency
3.
IGSF8: A Rising Star in Cancer Immunotherapy - Harnessing the Innate Immune System
4.
Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes
5.
Different Types of Blood Dyscrasias
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
2.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Further Discussion on A New Perspective
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
4.
Virtual Case Study on Pedal Edema and Triple Vessel Disease - An Initiative by Hidoc Dr.
5.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation